Getinge AB (OTCPK:GNGBF)
$ 17.85 0 (0%) Market Cap: 4.95 Bil Enterprise Value: 5.58 Bil PE Ratio: 29.80 PB Ratio: 1.49 GF Score: 86/100

Q2 2021 Getinge AB Earnings Call Transcript

Jul 16, 2021 / 08:00AM GMT
Release Date Price: $38.1
Operator

Hello, and welcome to the Getinge AB Audiocast on teleconference Q2 2021. (Operator Instructions) Just to remind you, this conference call is being recorded. I'll now hand the floor to Mattias Perjos, CEO. Please begin, sir.

Mattias Perjos
Getinge AB - CEO, President & Director

Thank you very much. With me on today's call, I have Lars Sandstrom, our CFO, who will take you through the financials a little bit later. Let's start with moving over to Page #2 right away and look at the key takeaways from the second quarter of 2021.

Organic net sales growth was 3.6% for the quarter. It's mainly explained by a tail of demand for (inaudible) related to COVID-19 in India. In combination with continued strong development in hemotherapy products is Life Science business area and a comeback in cardiovascular devices. Order intake decreased organically by 6.1% compared to 2020, when we had an exception of COVID-19 related order intake, especially in ventilators. We had a favorable product mix and continuous productivity improvements, and this resulted in higher

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot